Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Evotec AG ( (EVO) ).
On January 2, 2026, Evotec SE reported to the U.S. Securities and Exchange Commission that it had submitted Notifications of Major Holdings to the German financial regulator, in line with local transparency rules on significant shareholdings. The filings disclose that, as of December 24, 2025, JPMorgan Chase & Co.’s total voting interest in Evotec fell to 3.64%, down from 5.62%, combining direct shareholdings and financial instruments. This reduction in a major institutional holder’s stake may signal a shift in Evotec’s shareholder structure and could be relevant for investors monitoring changes in the company’s ownership and governance landscape.
The most recent analyst rating on (EVO) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Evotec AG stock, see the EVO Stock Forecast page.
Spark’s Take on EVO Stock
According to Spark, TipRanks’ AI Analyst, EVO is a Neutral.
Evotec AG’s overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. The company is struggling with profitability and cash flow issues, reflected in a negative P/E ratio and lack of dividend yield. Technical analysis shows a bearish trend, further weighing on the score. Despite some positive developments from the earnings call, such as growth in the Biologics segment and strategic partnerships, these are not enough to offset the significant financial challenges.
To see Spark’s full report on EVO stock, click here.
More about Evotec AG
Evotec SE is a Germany-based biotechnology company focused on drug discovery and development solutions, partnering with pharmaceutical and biotech firms to advance therapies across multiple disease areas. Listed in the U.S. as a foreign private issuer, the company operates under German and international securities regulations, reflecting its role in global capital markets.
Average Trading Volume: 129,887
Technical Sentiment Signal: Sell
Current Market Cap: $1.14B
For detailed information about EVO stock, go to TipRanks’ Stock Analysis page.